Literature DB >> 33547857

Microproteomic sample preparation.

Michal Alexovič1, Ján Sabo1, Rémi Longuespée2.   

Abstract

Multiple applications of proteomics in life and health science, pathology and pharmacology, require handling size-limited cell and tissue samples. During proteomic sample preparation, analyte loss in these samples arises when standard procedures are used. Thus, specific considerations have to be taken into account for processing, that are summarised under the term microproteomics (μPs). Microproteomic workflows include: sampling (e.g., flow cytometry, laser capture microdissection), sample preparation (possible disruption of cells or tissue pieces via lysis, protein extraction, digestion in bottom-up approaches, and sample clean-up) and analysis (chromatographic or electrophoretic separation, mass spectrometric measurements and statistical/bioinformatic evaluation). All these steps must be optimised to reach wide protein dynamic ranges and high numbers of identifications. Under optimal conditions, sampling is adapted to the studied sample types and nature, sample preparation isolates and enriches the whole protein content, clean-up removes salts and other interferences such as detergents or chaotropes, and analysis identifies as many analytes as the instrumental throughput and sensitivity allow. In the suggested review, we present and discuss the current state in μP applications for processing of small number of cells (cell μPs) and microscopic tissue regions (tissue μPs).
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  bottom-up approach; cell microproteomics; mass spectrometry; microproteomics; protein analysis; sample preparation; tissue microproteomics; top-down approach

Year:  2021        PMID: 33547857     DOI: 10.1002/pmic.202000318

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  6 in total

1.  Urinary Proteomics Reveals Promising Biomarkers in Menstrually Related and Post-Menopause Migraine.

Authors:  Elisa Bellei; Stefania Bergamini; Cecilia Rustichelli; Emanuela Monari; Michele Dal Porto; Alessandro Fiorini; Aldo Tomasi; Anna Ferrari
Journal:  J Clin Med       Date:  2021-04-24       Impact factor: 4.241

Review 2.  State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia-A Short Review and Diagnostic Algorithm.

Authors:  Eino Solje; Alberto Benussi; Emanuele Buratti; Anne M Remes; Annakaisa Haapasalo; Barbara Borroni
Journal:  Diagnostics (Basel)       Date:  2021-04-27

Review 3.  Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.

Authors:  Margit Zweyer; Hemmen Sabir; Paul Dowling; Stephen Gargan; Sandra Murphy; Dieter Swandulla; Kay Ohlendieck
Journal:  Histol Histopathol       Date:  2021-12-07       Impact factor: 2.303

Review 4.  Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction.

Authors:  Nutnicha Sirikaew; Dumnoensun Pruksakorn; Parunya Chaiyawat; Somchai Chutipongtanate
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

5.  Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence.

Authors:  Ombretta Repetto; Federica Lovisa; Caterina Elia; Daniel Enderle; Filippo Romanato; Salvatore Buffardi; Alessandra Sala; Marta Pillon; Agostino Steffan; Roberta Burnelli; Lara Mussolin; Maurizio Mascarin; Valli De Re
Journal:  Diagnostics (Basel)       Date:  2021-05-21

6.  Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma.

Authors:  Margaux Fresnais; Sevin Turcan; Dirk Theile; Johannes Ungermann; Yasmin Abou Zeed; Joshua Raoul Lindner; Marius Breitkopf; Jürgen Burhenne; Walter E Haefeli; Rémi Longuespée
Journal:  Biomedicines       Date:  2021-12-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.